معرفی
Michelle Savoie is a tenured Professor of Practical Training at the University of Montreal's Faculty of Pharmacy and President of Consilio Manuque. With over 25 years of experience in healthcare and the pharmaceutical industry, she has held strategic roles at companies like Schering Canada, Eli Lilly Canada, and Bristol-Myers Squibb. She previously served as CEO of Montréal InVivo until 2015. Her teaching focuses on drug development, reimbursement policies, and public health. She chairs the Groupe de recherche en gestion thérapeutique at the Faculty of Medicine and has contributed to initiatives such as the Quebec Consortium for Drug Discovery and NEOMED.
Education: B.Sc. in Biochemistry (Université Laval), MBA (University of Ottawa), Master's in Public Health (Boston University), Master's in Health Law and Policy (Université de Sherbrooke), Ph.D. in Biomedical Sciences (University of Montreal), and IAS.A. accreditation from the Institut des administrateurs de sociétés.
Research Interests: Strategic analysis in pharmaceutical markets, health economics, drug reimbursement policies, and personalized healthcare strategies. Her work emphasizes comparative analyses of healthcare policies across jurisdictions and optimizing early-stage drug development strategies.
Grants & Projects:
- 2024-2025: Multiple MITACS-funded projects on drug coverage comparisons, reimbursement criteria analysis, and early-phase oncology therapy evaluations.
- 2021-2022: FRQS grant for the Faculty of Pharmacy's centennial gala.
- 2017-2018: Co-funded by MITACS and Quebec's Ministry of Economy for a validated market positioning model.
Leadership & Affiliations:
- Board member of Institut NÉOMED and the International Congress on Personalized Healthcare.
- Member of the Fonds de solidarité FTQ Investment Committee.
- Co-founder of the Quebec Consortium for Drug Discovery and the Montreal Early Clinical Research Hub.
